Standout Papers

Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomi... 2010 2026 2015 2020 902
  1. Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study (2010)
    Federico Cappuzzo, Tudor–Eliade Ciuleanu et al. The Lancet Oncology

Immediate Impact

1 by Nobel laureates 35 from Science/Nature 83 standout
Sub-graph 1 of 20

Citing Papers

Renal cell carcinoma
2024 Standout
Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides
2023 StandoutNature
9 intermediate papers

Works of Emilio Esteban being referenced

Adjuvant MAGE-A3 Immunotherapy in Resected Non–Small-Cell Lung Cancer: Phase II Randomized Study Results
2013
MAGRIT phase III trial in adjuvant NSCLC: MAGE-A3 gene expression frequency on the first 2150 patients screened and demographics of first patients randomized
2009
and 4 more

Author Peers

Author Last Decade Papers Cites
Emilio Esteban 2586 2287 1212 164 4.1k
Zhijie Wang 1820 2189 955 171 3.6k
Tommaso De Pas 2081 2412 944 151 4.1k
William J. John 2839 2944 944 83 4.4k
Á. Artal 2408 3107 854 82 4.2k
Anna Spreafico 1148 2261 1199 224 3.6k
Takaaki Arigami 1438 1829 734 186 3.5k
Chunxia Su 2258 2533 1288 177 4.3k
Lauren C. Harshman 2646 1722 1324 191 4.2k
Shigeki Shimizu 1897 1407 1024 106 3.4k
Leonard J. Appleman 1157 1481 1304 176 3.3k

All Works

Loading papers...

Rankless by CCL
2026